TDR Targets

Basic information

Technical information

Name: Unnamed compound
MW: 325.835 | Formula: C19H20ClN3
H donors: 1 H acceptors: 1 LogP: 4.01 Rotable bonds: 4
Rule of 5 violations (Lipinski): 1
SMILES: N#Cc1ccc(cc1CN(c1ccccc1)C1CCNCC1)Cl
InChi: 1S/C19H20ClN3/c20-17-7-6-15(13-21)16(12-17)14-23(18-4-2-1-3-5-18)19-8-10-22-11-9-19/h1-7,12,19,22H,8-11,14H2
InChiKey: RWCCKHBTGXKDKL-UHFFFAOYSA-N

Network

Hover on a compound node to display the structore

Target Layer

Model Organisms

Species	Viewmode
Arabidopsis thaliana
Caenorhabditis elegans
Dictyostelium discoideum
Drosophila melanogaster
Escherichia coli
Homo sapiens
Mus musculus
Oryza sativa
Saccharomyces cerevisiae
Schmidtea mediterranea
Other organisms

TDR Pathogens:

Species	Viewmode
Brugia malayi
Chlamydia trachomatis
Echinococcus granulosus
Entamoeba histolytica
Echinococcus multilocularis
Giardia lamblia
Leishmania major
Loa Loa (eye worm)
Mycobacterium leprae
Mycobacterium tuberculosis
Mycobacterium ulcerans
Onchocerca volvulus
Plasmodium falciparum
Plasmodium vivax
Schistosoma mansoni
Trypanosoma brucei
Trypanosoma cruzi
Toxoplasma gondii
Treponema pallidum
Trichomonas vaginalis
Wolbachia endosymbiont of Brugia malayi

Other Pathogens:

Species	Viewmode
Babesia bovis
Candida albicans
Cryptosporidium hominis
Cryptosporidium parvum
Leishmania braziliensis
Leishmania donovani
Leishmania infantum
Leishmania mexicana
Neospora caninum
Plasmodium berghei
Plasmodium knowlesi
Plasmodium yoelii
Schistosoma japonicum
Trypanosoma brucei gambiense
Trypanosoma congolense
Theileria parva

Compound Layer

This is a work in progress. Come back soon to try this features!

Clustering layers

This is a work in progress. Come back soon to try this features!

Synonyms

No synonyms found for this compound

Targets

Known targets for this compound

Species	Target name	Source	Bibliographic reference
Homo sapiens	nitric oxide synthase 2, inducible	Starlite/ChEMBL	References

Predicted pathogen targets for this compound

By orthology

No druggable targets predicted by orthology data

By sequence similarity to non orthologous known druggable targets

No druggable targets predicted by sequence similarity

Ranking Plot

Putative Targets List

Species	Potential target	Raw	Global	Species
Entamoeba histolytica	type A flavoprotein, putative	0.0012	0.1242	0.5
Entamoeba histolytica	type A flavoprotein, putative	0.0012	0.1242	0.5
Loa Loa (eye worm)	cytochrome P450 family protein	0.0015	0.2246	0.2517
Leishmania major	p450 reductase, putative	0.0032	0.7734	1
Loa Loa (eye worm)	FAD binding domain-containing protein	0.0032	0.7734	0.8666
Trichomonas vaginalis	NADPH fad oxidoreductase, putative	0.0029	0.6539	0.7663
Trichomonas vaginalis	sulfite reductase, putative	0.0032	0.7734	0.9392
Schistosoma mansoni	NADPH flavin oxidoreductase	0.0016	0.2517	0.203
Brugia malayi	Voltage-gated potassium channel, HERG (KCNH2)-related. C. elegans unc-103 ortholog	0.0036	0.8925	1
Echinococcus multilocularis	methionine synthase reductase	0.002	0.3712	0.373
Loa Loa (eye worm)	flavodoxin family protein	0.0012	0.1242	0.1391
Mycobacterium ulcerans	formate dehydrogenase H FdhF	0.0032	0.7734	1
Schistosoma mansoni	5-methyl tetrahydrofolate-homocysteine methyltransferase reductase	0.002	0.3712	0.3303
Loa Loa (eye worm)	cytochrome P450 family protein	0.0015	0.2246	0.2517
Brugia malayi	Cytochrome P450 family protein	0.0025	0.552	0.5905
Trypanosoma brucei	NADPH--cytochrome P450 reductase, putative	0.0032	0.7734	1
Trypanosoma cruzi	cytochrome P450, putative	0.0015	0.2246	0.1547
Schistosoma mansoni	voltage-gated potassium channel	0.0039	1	1
Leishmania major	cytochrome P450 reductase, putative	0.0029	0.6539	0.8159
Toxoplasma gondii	flavodoxin domain-containing protein	0.0016	0.2437	0.5
Chlamydia trachomatis	sulfite reductase	0.002	0.3712	0.5
Entamoeba histolytica	type A flavoprotein, putative	0.0012	0.1242	0.5
Trypanosoma brucei	NADPH--cytochrome P450 reductase, putative	0.0032	0.7734	1
Loa Loa (eye worm)	hypothetical protein	0.0031	0.7379	0.8268
Brugia malayi	FAD binding domain containing protein	0.002	0.3712	0.373
Giardia lamblia	Nitric oxide synthase, inducible	0.0029	0.6539	0.5
Loa Loa (eye worm)	hypothetical protein	0.0032	0.7734	0.8666
Plasmodium vivax	NADPH-cytochrome p450 reductase, putative	0.0032	0.7734	1
Schistosoma mansoni	diflavin oxidoreductase	0.0016	0.2437	0.1945
Loa Loa (eye worm)	hypothetical protein	0.001	0.0611	0.0684
Trypanosoma cruzi	cytochrome P450, putative	0.0015	0.2246	0.1547
Trypanosoma brucei	cytochrome P450, putative	0.0015	0.2246	0.1547
Brugia malayi	Cytochrome P450 family protein	0.0015	0.2246	0.1967
Trichomonas vaginalis	voltage and ligand gated potassium channel, putative	0.0034	0.8155	1
Echinococcus granulosus	NADPH cytochrome P450 reductase	0.0032	0.7734	0.8568
Echinococcus granulosus	potassium voltage gated channel subfamily H	0.0036	0.8925	1
Treponema pallidum	flavodoxin	0.0012	0.1242	0.5
Trypanosoma cruzi	cytochrome P450 reductase, putative	0.0032	0.7734	1
Brugia malayi	flavodoxin family protein	0.0032	0.7734	0.8568
Trypanosoma brucei	NADPH-cytochrome p450 reductase, putative	0.0032	0.7734	1
Trichomonas vaginalis	voltage and ligand gated potassium channel, putative	0.0034	0.8155	1
Plasmodium falciparum	nitric oxide synthase, putative	0.0032	0.7734	1
Leishmania major	cytochrome p450-like protein	0.0015	0.2246	0.1547
Echinococcus multilocularis	NADPH dependent diflavin oxidoreductase 1	0.0032	0.7734	0.8568
Echinococcus granulosus	NADPH dependent diflavin oxidoreductase 1	0.0032	0.7734	0.8568
Echinococcus multilocularis	potassium voltage gated channel subfamily H	0.0036	0.8925	1
Brugia malayi	Cytochrome P450 family protein	0.0015	0.2246	0.1967
Loa Loa (eye worm)	cytochrome P450 family protein	0.0025	0.552	0.6186
Brugia malayi	flavodoxin family protein	0.0012	0.1242	0.0759
Trypanosoma cruzi	p450 reductase, putative	0.0032	0.7734	1
Brugia malayi	FAD binding domain containing protein	0.0032	0.7734	0.8568
Echinococcus granulosus	methionine synthase reductase	0.002	0.3712	0.373
Echinococcus multilocularis	NADPH cytochrome P450 reductase	0.0032	0.7734	0.8568
Trypanosoma cruzi	cytochrome P450 reductase, putative	0.0032	0.7734	1
Toxoplasma gondii	flavodoxin domain-containing protein	0.0016	0.2437	0.5
Entamoeba histolytica	type A flavoprotein, putative	0.0012	0.1242	0.5
Entamoeba histolytica	type A flavoprotein, putative	0.0012	0.1242	0.5
Loa Loa (eye worm)	CYP4Cod1	0.0015	0.2246	0.2517
Leishmania major	NADPH-cytochrome p450 reductase-like protein	0.0032	0.7734	1
Trypanosoma cruzi	NADPH-dependent FMN/FAD containing oxidoreductase, putative	0.0032	0.7734	1
Plasmodium vivax	flavodoxin domain containing protein	0.0029	0.6539	0.8159
Trypanosoma brucei	NADPH-dependent diflavin oxidoreductase 1	0.0032	0.7734	1
Loa Loa (eye worm)	voltage and ligand gated potassium channel	0.0036	0.8925	1
Schistosoma mansoni	cytochrome P450 reductase	0.0032	0.7734	0.7587
Loa Loa (eye worm)	FAD binding domain-containing protein	0.002	0.3712	0.416
Giardia lamblia	Hypothetical protein	0.0029	0.6539	0.5

Activities

Activity type	Activity value	Assay description	Source	Reference
IC50 (binding)	= 660 nM	Inhibition of human iNOS expressed in human DLD1 cells after 1 hr	ChEMBL.	18024030
IC50 (binding)	= 660 nM	Inhibition of human iNOS expressed in human DLD1 cells after 1 hr	ChEMBL.	18024030
IC50 (binding)	= 8000 nM	Inhibition of cytokine-induced iNOS activity in human DLD1 cells after 24 hrs	ChEMBL.	18024030
IC50 (binding)	= 8000 nM	Inhibition of cytokine-induced iNOS activity in human DLD1 cells after 24 hrs	ChEMBL.	18024030
Inhibition (binding)	= 0 %	Inhibition of human eNOS expressed in insect SF9 cells at 10 uM after 1 hr	ChEMBL.	18024030
Inhibition (binding)	= 0 %	Inhibition of human eNOS expressed in insect SF9 cells at 10 uM after 1 hr	ChEMBL.	18024030
Inhibition (binding)	= 33 %	Inhibition of human nNOS expressed in insect SF9 cells at 10 uM after 1 hr	ChEMBL.	18024030
Inhibition (binding)	= 33 %	Inhibition of human nNOS expressed in insect SF9 cells at 10 uM after 1 hr	ChEMBL.	18024030
Ratio IC50 (binding)	> 15	Selectivity for human eNOS to human iNOS	ChEMBL.	18024030
Ratio IC50 (binding)	> 15	Selectivity for human nNOS to human iNOS	ChEMBL.	18024030

Phenotypes

Whole-cell/tissue/organism interactions

We have no records of whole-cell/tissue assays done with this compound What does this mean?

Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.

Annotated phenotypes:

We have no manually annotated phenotypes for this drug. What does this mean? / Care to help?

In TDR Targets, information about phenotypes that are caused by drugs, or by genetic manipulation of cells (e.g. gene knockouts or knockdowns) is manually curated from the literature. These descriptions help to describe the potential of the target for drug development. If no information is available for this gene or if the information is incomplete, this may mean that i) the papers containing this information either appeared after the curation effort for this organism was carried out or they were inadvertently missed by curators; or that ii) the curation effort for this organism has not yet started.

In any case, if you have information about papers containing relevant validation data for this target, please log in using your TDR Targets username and password and send them to us using the corresponding form in this page (only visible to registered users) or contact us.

External resources for this compound

ChEMBL: CHEMBL271247

Bibliographic References

1 literature reference was collected for this gene.

If you have references for this compound, please enter them in a user comment (below) or Contact us.

Detailed information for compound 520865